Philips reclassified to STOXX Europe 600 Health Care sector index

March 20, 2017

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that its sector classification for the STOXX Europe 600 Index has changed to Health Care from Industrial Goods & Services. The reclassification will be effective as of the open of European markets today. 

 

The component selection lists that are used for STOXX indices are based on the FTSE Group’s Industry Classification Benchmark (ICB). In December 2016, FTSE Group’s ICB reclassified Philips to Health Care industry* from Industrials industry.

 

“The STOXX sector reclassification to Health Care underlines the significant steps that we have taken to transform Philips into a focused leader in health technology,” said Frans van Houten, CEO of Royal Philips. “2016 was a defining year in our transformation, and we have seen the results of our strategic focus reflected in our performance and the positive response from our stakeholders, including our employees, customers and shareholders. This reclassification will further facilitate the comparison with sector peers and support the investment community to value Philips going forward.”

 

More information about the STOXX Europe 600 Healthcare sector index can be found here.

 

* ICB supersector, sector and subsector classifications are Health Care, Health Care Equipment & Services and Medical Equipment respectively. 

For further information, please contact:

Steve Klink

Philips Group Press Office

Tel.: +31 6 10888824

E-mail: steve.klink@philips.com

 

Ksenija Gonciarenko

Philips Investor Relations

Tel: +31 6 31914905

E-mail: ksenija.gonciarenko@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 71,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.